|
BRIX1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.516260E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.879700E-02 |
| Normal-vs-Stage2 |
4.740000E-01 |
| Normal-vs-Stage3 |
5.835900E-02 |
| Normal-vs-Stage4 |
2.697000E-03 |
| Stage1-vs-Stage2 |
6.227900E-02 |
| Stage1-vs-Stage3 |
5.448000E-01 |
| Stage1-vs-Stage4 |
3.289700E-02 |
| Stage2-vs-Stage3 |
5.490300E-02 |
| Stage2-vs-Stage4 |
2.037100E-03 |
| Stage3-vs-Stage4 |
1.086390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.587640E-02 |
| Normal-vs-AfricanAmerican |
7.882100E-02 |
| Normal-vs-Asian |
4.537500E-03 |
| Caucasian-vs-AfricanAmerican |
5.204000E-01 |
| Caucasian-vs-Asian |
2.262200E-01 |
| AfricanAmerican-vs-Asian |
8.027400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.429500E-02 |
| Normal-vs-Female |
1.742470E-02 |
| Male-vs-Female |
7.671200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.347500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.301800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.200820E-01 |
| Normal-vs-Age(81-100Yrs) |
1.161040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.524200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.886200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.109800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.414000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.000960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.489200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.272400E-01 |
| Classical-VS-Follicular |
6.43169961733747E-10 |
| Classical-VS-Other |
9.041400E-01 |
| Classical-VS-Normal |
7.98670000000667E-05 |
| Tall-VS-Follicular |
4.044800E-04 |
| Tall-VS-Other |
8.767400E-01 |
| Tall-VS-Normal |
2.502200E-02 |
| Follicular-VS-Other |
7.510400E-02 |
| Follicular-VS-Normal |
1.577710E-02 |
| Other-VS-Normal |
4.005400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.646200E-01 |
| Normal-vs-N1 |
4.879500E-03 |
| N0-vs-N1 |
2.120200E-03 |
|
|
